U.S. Food and Drug Administration
Share
The official page of the U.S. Food and Drug Administration. Our posts are all FDA APPROVED! The U.S. Food and Drug Administration or the federal government.
Food and Drug Administration maintains Facebook, Instagram, Threads, X and other social media accounts to share updates about FDA activities and public-health-related information about FDA-regulated products. The FDA has instituted the following policy regarding comments posted to FDA’s social media accounts:
General Comment Guidelines
To maintain respectful interaction on this page, we encourage that all comments:
- Stay focused. All viewpoints are welcome, but comments should be relevant to the specific post under which it appears.
- Be respectful. Respect others’ opinions and share your opinions in a respectful way.
- Tell the truth. Spreading false or misleading information about FDA-regulated products harms the public health.
- No spam. This includes unsolicited commercial messages and a single user’s repeated comments on a topic unrelated to the underlying post. Comment Expectations
Although we hope that you choose to contribute your comments, to protect privacy, please do not disclose personally identifiable information about yourself or other individuals. We welcome your comments and request that you respect the informational resources provided by FDA’s social media accounts. Also, any comments, posts or links that seek to defame, slander or libel any current or former employees (including contractors) of the FDA will be hidden or removed. We will consider your comments when posting new updates, but we may not respond directly to individual inquiries. We are unable to answer questions about your specific health care situation. The FDA does not endorse the comments or opinions provided by visitors to its social media accounts. FDA following users or sharing content does not imply FDA endorsement. We retain the discretion to determine which comments violate our comment policy. We also reserve the right to hide or remove comments and/or disable commenting. The views expressed within posted comments do not necessarily reflect those of the U.S. Comment Moderation
Depending on the platform, comments may be filtered, hidden, and/or removed. We are using these terms to mean the following:
“Filtered” or “filtered and hidden” means that the platform or agency system automatically flagged the comment. It is typically hidden from most users but may still be visible to a limited subset of users.
“Hidden” means that the agency manually flagged the comment to be hidden from most users, but that it may still exist on the platforms in a limited fashion.
“Removed” and “deleted” have the same definition and mean that the agency manually removed the comment from the platform. A record of that removed comment is preserved in accordance with FDA’s Social Media Policy and the Records Retention Schedule. Comments may be automatically filtered and hidden by the social media platform if:
- The comment contains profanity.
- The comment contains an image.
- The comment contains a video.
- The comment contains a link/URL.
- The comment contains keywords from known scam attempts.
- The user does not have a profile picture.
- The user has had their account for one week or less.
- The user does not have any friends or followers.
- The user has had at least three comments reported, deleted, or hidden in the previous 30 days. Comments visible on social media accounts may be hidden or removed by FDA if they:
- Were not hidden despite matching the automated filter criteria as outlined above.
- Appear to be spam, including comments containing commercial endorsements, commercial solicitations, WhatsApp numbers, or a single user’s repeated comments on a topic unrelated to the underlying post.
- Contain discriminatory, racist, offensive, obscene, inflammatory, threatening, or unlawful statements, language, or content.
- Include personally identifiable information for individuals such as email addresses, phone numbers, and mailing addresses.
- Violate the comment policy. Because we want to avoid commercial solicitations and malicious links in our comments, our filters hide comments that contain URLs. To the extent a commenter wishes to reference relevant material available from other sources, please provide a citation or other bibliographic information without including a link. If you think your comment may have been hidden or removed in error, please contact us at [email protected] with details. Records will be kept of all comments that are removed by FDA for the above reasons. We reserve the right to block offenders of this policy.
10/02/2026
Recalled fresh jalapeños from Sinaloa, Mexico, distributed by Coast Citrus Distributors, are no longer for sale and are past shelf life.
Check your home and discard recalled jalapeños or return them for a refund. https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-salmonella-jalapeno-august-2026
10/01/2026
Today, we approved the first heart valve device designed to grow with children. The Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease can be expanded after surgery to keep pace with growth. The adjustable valve may mean fewer repeat surgeries for children as they get older.
https://www.fda.gov/news-events/press-announcements/fda-approves-first-heart-valve-designed-grow-children
Congenital heart defects are among the most common types of birth defects in the United States, affecting about 1 in every 100 births. The valve was approved through the premarket approval pathway, the FDA's most rigorous review process for medical devices.
09/30/2026
Today, we’re announcing a broad, nationwide recruitment effort to fill vacancies on FDA’s advisory committees – the independent expert bodies that inform some of the most consequential decisions in American public health. https://www.fda.gov/news-events/press-announcements/fda-launches-nationwide-effort-expand-scientific-expertise-and-consumer-voices-advisory-committees
Advisory committees are a cornerstone of FDA’s science-based, transparent regulatory process. They bring together clinicians, scientists, and patient and community advocates to provide independent recommendations that help us make well-informed decisions on behalf of the American public.
To learn more and to submit a nomination, visit FDA’s centralized application portal at http://www.fda.gov/advisory-committees/advisory-committee-membership/applying-membership-fda-advisory-committees.
FDA has free resources to support you and your baby before, during, and after your . Read and share FDA’s resources to learn more. 💗
https://www.fda.gov/consumers/knowledge-and-news-women-owh-blog/maternal-health-matters
09/29/2026
You don’t have to navigate alone. Visit FDA’s free resources to learn about common symptoms, treatment options, and more. Read & share! www.fda.gov/uterinefibroids
09/28/2026
The FDA wants to hear from you! The FDA is hosting two listening sessions, one for patients and caregivers, and another for healthcare professionals. If you are a patient or caregiver for someone who has received a solid organ transplant and has taken any of the below immunosuppressant medications (brand name and/or generic), or a healthcare professional who works closely with patients taking any of the below medications, we invite you to share your experience directly with FDA staff.
Cyclosporin Capsule (generic)
Sandimmune Capsule or Oral Solution
Neoral Capsule or Oral Solution
Tacrolimus Capsule (generic)
Prograf Capsule
Astagraf XL Capsule
Envarsus Tablet, Extended Release
Sirolimus Tablet (generic)
Rapamune Tablet
Everolimus Tablet (generic)
Zortress Tablet
What: FDA Listening Sessions on Immunosuppressant Medications
When: Wednesday, November 4th at 11:30am – 1pm ET Session 1 (Patient Session)
Wednesday, November 4th at 2 pm – 3:30pm ET Session 2 (Healthcare professional Session)
What happens at a Listening Session?
A small group of people (patients, caregivers, or healthcare professionals) share their firsthand experiences with FDA staff. We want to understand the patient experience, and healthcare professional perspective, so it can inform our work.
Who can participate?
Session 1: Patients, and caregivers of patients, who are currently taking, or have previously taken, any of the medications listed above (generic or brand-name versions). Session 2: Healthcare professionals who work regularly with patients taking the above medications.
Participants will be selected based on various factors including age and geographic location to ensure a variety of perspectives.
How to apply:
Space is very limited. If you're interested in participating, please complete this brief interest survey by Friday, October 2nd:
Patients and Caregivers: https://qualtricsxmjqffz4ktl.qualtrics.com/jfe/form/SV_8IzzhuoebcPCdG6
Healthcare Professionals: https://qualtricsxmjqffz4ktl.qualtrics.com/jfe/form/SV_bm7Y4ZaqqLzmjdk
09/28/2026
Polycystic o***y syndrome has a new name – polyendocrine metabolic ovarian syndrome. Learn more about what this means for you and talk with your health care provider about your risk. https://www.fda.gov/consumers/womens-health-topics/polycystic-o***y-syndrome-pcos
09/25/2026
Products include medium cheddar, sharp cheddar, jalapeño jack and Monterey jack cheese sold in 8-oz or 16-oz packages and available to food service customers or wholesalers in 5-lb loaves.
Consumers can return recalled cheese to the place of purchase for a refund. https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-e-coli-o26h11-raw-milk-cheese-september-2026
09/25/2026
Pharmacists help answer important questions about medicines, including .
Whether discussing treatment options with patients or collaborating with other members of the health care team, staying informed about biosimilars can support informed decision-making. Explore FDA's "9 Things to Know About Biosimilars and Interchangeable Biosimilars":
https://www.fda.gov/drugs/things-know-about/9-things-know-about-biosimilars-and-interchangeable-biosimilars
09/25/2026
What you eat matters — and when it comes to , nutrition plays a bigger role than you may think. The FDA Office of Women’s Health has tools to help you and your family navigate food choices.
Read our blog, “Know Your Nutrition: Empowering Women to Make Informed Food Choices” to learn more:
https://www.fda.gov/consumers/knowledge-and-news-women-owh-blog/know-your-nutrition-empowering-women-make-informed-food-choices
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
10903 New Hampshire Avenue
Silver Spring, MD
20993
Alerts
Be the first to know and let us send you an email when U.S. Food and Drug Administration posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.